$PTIX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Protagenic Therapeutics, Inc.\new.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Protagenic Therapeutics, Inc.\new. Get notifications about new insider transactions in Protagenic Therapeutics, Inc.\new for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 01 2021 | PTIX | Protagenic Therape ... | Arrow Alexander K. | Chief Financial Off ... | Option Exercise | P | 4.98 | 3,000 | 14,940 | 33,000 | |
May 05 2021 | PTIX | Protagenic Therape ... | Barrage Khalil | Director | Option Exercise | M | 1.75 | 120,000 | 210,000 | 0 | |
May 05 2021 | PTIX | Protagenic Therape ... | Barrage Khalil | Director | Option Exercise | M | 1.75 | 45,000 | 78,750 | 120,000 | |
May 05 2021 | PTIX | Protagenic Therape ... | Barrage Khalil | Director | Option Exercise | M | 1.25 | 150,000 | 187,500 | 165,000 | |
May 05 2021 | PTIX | Protagenic Therape ... | Barrage Khalil | Director | Option Exercise | M | 1.25 | 45,000 | 56,250 | 315,000 | |
May 05 2021 | PTIX | Protagenic Therape ... | Barrage Khalil | Director | Buy | M | 1.75 | 120,000 | 210,000 | 410,000 | 290 K to 410 K (+41.38 %) |
May 05 2021 | PTIX | Protagenic Therape ... | Barrage Khalil | Director | Buy | M | 1.75 | 45,000 | 78,750 | 290,000 | 245 K to 290 K (+18.37 %) |
May 05 2021 | PTIX | Protagenic Therape ... | Barrage Khalil | Director | Buy | M | 1.25 | 150,000 | 187,500 | 245,000 | 95 K to 245 K (+157.89 %) |
May 05 2021 | PTIX | Protagenic Therape ... | Barrage Khalil | Director | Buy | M | 1.25 | 45,000 | 56,250 | 95,000 | 50 K to 95 K (+90.00 %) |
May 03 2021 | PTIX | Protagenic Therape ... | Arrow Alexander K. | Chief Financial Off ... | Buy | P | 2.29 | 1,000 | 2,290 | 120,260 | 119.3 K to 120.3 K (+0.84 %) |
May 03 2021 | PTIX | Protagenic Therape ... | Arrow Alexander K. | Chief Financial Off ... | Buy | P | 2.29 | 1,000 | 2,290 | 119,260 | 118.3 K to 119.3 K (+0.85 %) |
Jul 21 2020 | PTIX | Protagenic Therape ... | Buell Jennifer | Director | Option Exercise | A | 1.75 | 145,000 | 253,750 | 145,000 | |
Jul 21 2020 | PTIX | Protagenic Therape ... | Arrow Alexander K. | Chief Financial Off ... | Option Exercise | A | 1.75 | 124,998 | 218,747 | 124,998 | |
Feb 26 2020 | PTIX | Protagenic Therape ... | Silverman Joshua | Director | Option Exercise | A | 1.75 | 120,000 | 210,000 | 120,000 | |
Feb 26 2020 | PTIX | Protagenic Therape ... | ARMEN GARO H | Executive Chairman | Option Exercise | A | 1.75 | 300,000 | 525,000 | 300,000 | |
Feb 26 2020 | PTIX | Protagenic Therape ... | Corvese Brian | Director | Option Exercise | A | 1.75 | 120,000 | 210,000 | 120,000 | |
Feb 26 2020 | PTIX | Protagenic Therape ... | Arrow Alexander K. | Chief Financial Off ... | Option Exercise | A | 1.75 | 307,497 | 538,120 | 307,497 | |
Feb 26 2020 | PTIX | Protagenic Therape ... | Stein Robert Benjamin | Director | Option Exercise | A | 1.75 | 150,000 | 262,500 | 150,000 | |
Feb 26 2020 | PTIX | Protagenic Therape ... | Barrage Khalil | Director | Option Exercise | A | 1.75 | 120,000 | 210,000 | 120,000 | |
Mar 25 2019 | PTIX | Protagenic Therape ... | Arrow Alexander K. | Chief Financial Off ... | Option Exercise | A | 1.00 | 41,667 | 41,667 | 41,667 | |
Oct 18 2017 | PTIX | Protagenic Therape ... | Corvese Brian | Director | Option Exercise | A | 1.75 | 95,000 | 166,250 | 95,000 | |
Oct 18 2017 | PTIX | Protagenic Therape ... | Arrow Alexander K. | Chief Financial Off ... | Option Exercise | A | 1.75 | 75,000 | 131,250 | 75,000 | |
Oct 18 2017 | PTIX | Protagenic Therape ... | ARMEN GARO H | Executive Chairman | Option Exercise | A | 1.75 | 250,000 | 437,500 | 250,000 | |
Oct 18 2017 | PTIX | Protagenic Therape ... | Stein Robert Benjamin | Director | Option Exercise | A | 1.75 | 200,000 | 350,000 | 200,000 | |
Oct 18 2017 | PTIX | Protagenic Therape ... | Silverman Joshua | Director | Option Exercise | A | 1.75 | 45,000 | 78,750 | 45,000 | |
Oct 18 2017 | PTIX | Protagenic Therape ... | Barrage Khalil | Director | Option Exercise | A | 1.75 | 45,000 | 78,750 | 45,000 | |
Aug 18 2016 | ATRN | Protagenic Therape ... | ARMEN GARO H | See Remarks | Buy | P | 1.25 | 60,211 | 75,264 | 4,299,379 | 4.2 M to 4.3 M (+1.42 %) |
Aug 10 2016 | ATRN | Protagenic Therape ... | Barrage Khalil | Director | Grant | A | 1.25 | 150,000 | 187,500 | 245,000 | 95 K to 245 K (+157.89 %) |
Jun 22 2016 | ATRN | Protagenic Therape ... | Ekizian Gregory | Director | Grant | A | 1.25 | 45,000 | 56,250 | 645,000 | 600 K to 645 K (+7.50 %) |
Jun 21 2016 | ATRN | Protagenic Therape ... | Arrow Alexander K. | Chief Financial Off ... | Grant | A | 1.25 | 140,000 | 175,000 | 358,260 | 218.3 K to 358.3 K (+64.14 %) |
Jun 21 2016 | ATRN | Protagenic Therape ... | ARMEN GARO H | See Remarks | Grant | A | 1.25 | 500,000 | 625,000 | 4,239,168 | 3.7 M to 4.2 M (+13.37 %) |
Jun 21 2016 | ATRN | Protagenic Therape ... | Silverman Joshua | Director | Grant | A | 1.25 | 45,000 | 56,250 | 45,000 | 0 to 45 K |
Jun 21 2016 | ATRN | Protagenic Therape ... | Barrage Khalil | Director | Grant | A | 1.25 | 45,000 | 56,250 | 245,000 | 200 K to 245 K (+22.50 %) |
Jun 21 2016 | ATRN | Protagenic Therape ... | Stein Robert Benjamin | Director | Grant | A | 1.25 | 40,000 | 50,000 | 240,000 | 200 K to 240 K (+20.00 %) |
May 10 2016 | ATRN | Atrinsic, Inc. | Arrow Alexander K. | Chief Financial Off ... | Option Exercise | P | 1.25 | 18,260 | 22,825 | 118,260 | |
May 10 2016 | ATRN | Atrinsic, Inc. | Arrow Alexander K. | Chief Financial Off ... | Option Exercise | P | 1.25 | 40,000 | 50,000 | 100,000 | |
Jun 02 2011 | ATRN | Atrinsic, Inc. | BRILLIANT DIGITAL ENTERTAINMEN ... | 10% Owner | Option Exercise | P | 2.97 | 360,345 | 1,070,225 | 360,345 | |
Jun 02 2011 | ATRN | Atrinsic, Inc. | BRILLIANT DIGITAL ENTERTAINMEN ... | 10% Owner | Option Exercise | P | 2.93 | 379,311 | 1,111,381 | 379,311 | |
Jun 02 2011 | ATRN | Atrinsic, Inc. | BRILLIANT DIGITAL ENTERTAINMEN ... | 10% Owner | Option Exercise | P | 2.90 | 758,621 | 2,200,001 | 758,621 | |
Jun 02 2011 | ATRN | Atrinsic, Inc. | BRILLIANT DIGITAL ENTERTAINMEN ... | 10% Owner | Option Exercise | P | 2.90 | 758,621 | 2,200,001 | 758,621 | |
Dec 15 2010 | ATRN | Atrinsic, Inc. | MUSCI RAYMOND | Exec VP, Corporate ... | Buy | P | 2.09 | 1,758 | 3,674 | 450,821 | 449.1 K to 450.8 K (+0.39 %) |
Dec 15 2010 | ATRN | Atrinsic, Inc. | MUSCI RAYMOND | Exec VP, Corporate ... | Buy | P | 2.08 | 300 | 624 | 449,063 | 448.8 K to 449.1 K (+0.07 %) |
Dec 15 2010 | ATRN | Atrinsic, Inc. | MUSCI RAYMOND | Exec VP, Corporate ... | Buy | P | 2.07 | 569 | 1,178 | 448,763 | 448.2 K to 448.8 K (+0.13 %) |
Dec 15 2010 | ATRN | Atrinsic, Inc. | MUSCI RAYMOND | Exec VP, Corporate ... | Buy | P | 2.00 | 74 | 148 | 448,194 | 448.1 K to 448.2 K (+0.02 %) |
Dec 15 2010 | ATRN | Atrinsic, Inc. | MUSCI RAYMOND | Exec VP, Corporate ... | Buy | P | 1.99 | 1,334 | 2,655 | 448,120 | 446.8 K to 448.1 K (+0.30 %) |
Dec 15 2010 | ATRN | Atrinsic, Inc. | MUSCI RAYMOND | Exec VP, Corporate ... | Buy | P | 1.98 | 900 | 1,782 | 446,786 | 445.9 K to 446.8 K (+0.20 %) |
Dec 15 2010 | ATRN | Atrinsic, Inc. | MUSCI RAYMOND | Exec VP, Corporate ... | Buy | P | 1.97 | 266 | 524 | 445,886 | 445.6 K to 445.9 K (+0.06 %) |
Dec 15 2010 | ATRN | Atrinsic, Inc. | MUSCI RAYMOND | Exec VP, Corporate ... | Buy | P | 1.90 | 5,000 | 9,500 | 445,620 | 440.6 K to 445.6 K (+1.13 %) |
Dec 15 2010 | ATRN | Atrinsic, Inc. | MUSCI RAYMOND | Exec VP, Corporate ... | Buy | P | 1.79 | 3,499 | 6,263 | 440,620 | 437.1 K to 440.6 K (+0.80 %) |
Dec 15 2010 | ATRN | Atrinsic, Inc. | MUSCI RAYMOND | Exec VP, Corporate ... | Buy | P | 1.70 | 100 | 170 | 437,121 | 437 K to 437.1 K (+0.02 %) |
Dec 15 2010 | ATRN | Atrinsic, Inc. | MUSCI RAYMOND | Exec VP, Corporate ... | Buy | P | 1.64 | 100 | 164 | 437,021 | 436.9 K to 437 K (+0.02 %) |
Dec 15 2010 | ATRN | Atrinsic, Inc. | MUSCI RAYMOND | Exec VP, Corporate ... | Buy | P | 1.63 | 600 | 978 | 436,921 | 436.3 K to 436.9 K (+0.14 %) |
Dec 15 2010 | ATRN | Atrinsic, Inc. | MUSCI RAYMOND | Exec VP, Corporate ... | Buy | P | 1.60 | 300 | 480 | 436,321 | 436 K to 436.3 K (+0.07 %) |
Dec 15 2010 | ATRN | Atrinsic, Inc. | MUSCI RAYMOND | Exec VP, Corporate ... | Buy | P | 1.59 | 200 | 318 | 436,021 | 435.8 K to 436 K (+0.05 %) |
Sep 30 2010 | ATRN | Atrinsic, Inc. | ELLIN ROBERT S | Director | Option Exercise | A | 0.00 | 37,610 | 0 | 37,610 | |
Sep 30 2010 | ATRN | Atrinsic, Inc. | DYNE MARK | Director | Option Exercise | A | 0.00 | 37,610 | 0 | 37,610 | |
Sep 30 2010 | ATRN | Atrinsic, Inc. | CHAZEN JEROME A | Director | Option Exercise | A | 0.00 | 64,159 | 0 | 64,159 | |
Sep 30 2010 | ATRN | Atrinsic, Inc. | BURSTEIN LAWRENCE | Director | Option Exercise | A | 0.00 | 37,610 | 0 | 37,610 | |
Jul 02 2010 | ATRN | Atrinsic, Inc. | Plotts Thomas | Chief Financial Off ... | Option Exercise | A | 0.91 | 250,000 | 227,500 | 250,000 | |
Jun 24 2010 | ATRN | Atrinsic, Inc. | Plotts Thomas | Interim CFO | Option Exercise | M | 0.00 | 25,000 | 0 | 0 | |
Jun 24 2010 | ATRN | Atrinsic, Inc. | Plotts Thomas | Interim CFO | Payment of Exercise | F | 0.82 | 9,718 | 7,969 | 28,619 | 38.3 K to 28.6 K (-25.35 %) |
Jun 24 2010 | ATRN | Atrinsic, Inc. | Plotts Thomas | Interim CFO | Buy | M | 0.00 | 25,000 | 0 | 38,337 | 13.3 K to 38.3 K (+187.45 %) |
Jun 07 2010 | ATRN | Atrinsic, Inc. | DYNE MARK | Director | Sell | J | 0.00 | 20,000 | 0 | 746,369 | 766.4 K to 746.4 K (-2.61 %) |
Mar 04 2010 | ATRN | Atrinsic, Inc. | CHAZEN JEROME A | Director | Buy | J | 0.00 | 41,049 | 0 | 53,234 | 12.2 K to 53.2 K (+336.88 %) |
Feb 02 2010 | ATRN | Atrinsic, Inc. | Plotts Thomas | Interim CFO | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Jan 29 2010 | ATRN | Atrinsic, Inc. | SCHWARTZ JEFFREY A | Chief Executive Off ... | Option Exercise | A | 0.75 | 500,000 | 375,000 | 500,000 | |
Jan 29 2010 | ATRN | Atrinsic, Inc. | SCHWARTZ JEFFREY A | Chief Executive Off ... | Option Exercise | A | 0.75 | 500,000 | 375,000 | 500,000 | |
Jan 07 2010 | ATRN | Atrinsic, Inc. | Trinad Capital Master Fund Ltd ... | 10% Owner | Sell | J | 0.00 | 1,323,467 | 0 | 1,792,695 | 3.1 M to 1.8 M (-42.47 %) |
Jan 07 2010 | ATRN | Atrinsic, Inc. | Trinad Capital Master Fund Ltd ... | 10% Owner | Buy | P | 0.60 | 5,376 | 3,226 | 3,116,262 | 3.1 M to 3.1 M (+0.17 %) |
Jan 07 2010 | ATRN | Atrinsic, Inc. | Trinad Capital Master Fund Ltd ... | 10% Owner | Buy | P | 0.65 | 527,683 | 342,888 | 3,110,886 | 2.6 M to 3.1 M (+20.43 %) |
Jan 07 2010 | ATRN | Atrinsic, Inc. | Trinad Capital Master Fund Ltd ... | 10% Owner | Buy | P | 0.67 | 21,947 | 14,704 | 2,583,203 | 2.6 M to 2.6 M (+0.86 %) |
Jan 07 2010 | ATRN | Atrinsic, Inc. | Trinad Capital Master Fund Ltd ... | 10% Owner | Buy | P | 0.66 | 86,386 | 56,989 | 2,561,256 | 2.5 M to 2.6 M (+3.49 %) |
Jan 07 2010 | ATRN | Atrinsic, Inc. | Trinad Capital Master Fund Ltd ... | 10% Owner | Buy | P | 0.85 | 25,000 | 21,250 | 2,474,870 | 2.4 M to 2.5 M (+1.02 %) |
Jan 07 2010 | ATRN | Atrinsic, Inc. | Trinad Capital Master Fund Ltd ... | 10% Owner | Buy | P | 0.85 | 50,500 | 42,925 | 2,449,870 | 2.4 M to 2.4 M (+2.10 %) |
Jan 07 2010 | ATRN | Atrinsic, Inc. | Trinad Capital Master Fund Ltd ... | 10% Owner | Buy | P | 0.86 | 50,000 | 42,920 | 2,399,370 | 2.3 M to 2.4 M (+2.13 %) |
Jan 07 2010 | ATRN | Atrinsic, Inc. | Trinad Capital Master Fund Ltd ... | 10% Owner | Buy | P | 0.85 | 11,100 | 9,435 | 2,349,370 | 2.3 M to 2.3 M (+0.47 %) |
Sep 21 2009 | ATRN | Atrinsic, Inc. | DYNE MARK | Director | Grant | A | 0.00 | 40,000 | 0 | 766,369 | 726.4 K to 766.4 K (+5.51 %) |
Jun 30 2009 | ATRN | Atrinsic, Inc. | SCHWARTZ JEFFREY A | Director | Grant | A | 0.00 | 3,892 | 0 | 3,892 | 0 to 3.9 K |
Jun 30 2009 | ATRN | Atrinsic, Inc. | ZAREF ANDREW | Chief Financial Off ... | Option Exercise | A | 0.00 | 200,000 | 0 | 200,000 | |
Jun 30 2009 | ATRN | Atrinsic, Inc. | ZAREF ANDREW | Chief Financial Off ... | Option Exercise | A | 0.00 | 66,667 | 0 | 66,667 | |
Jun 30 2009 | ATRN | Atrinsic, Inc. | ZAREF ANDREW | Chief Financial Off ... | Option Exercise | D | 4.16 | 200,000 | 832,000 | 0 | |
Jun 30 2009 | ATRN | Atrinsic, Inc. | Greenberger Zachary | Chief Technology Of ... | Option Exercise | A | 0.00 | 16,667 | 0 | 16,667 | |
Jun 30 2009 | ATRN | Atrinsic, Inc. | Greenberger Zachary | Chief Technology Of ... | Option Exercise | D | 6.00 | 50,000 | 300,000 | 0 | |
Jun 30 2009 | ATRN | Atrinsic, Inc. | Greenberger Zachary | Chief Technology Of ... | Option Exercise | A | 0.00 | 16,667 | 0 | 16,667 | |
Jun 30 2009 | ATRN | Atrinsic, Inc. | Greenberger Zachary | Chief Technology Of ... | Option Exercise | D | 6.00 | 50,000 | 300,000 | 0 | |
Jun 30 2009 | ATRN | Atrinsic, Inc. | DYNE MARK | Director | Grant | A | 0.00 | 3,892 | 0 | 3,892 | 0 to 3.9 K |
Jun 30 2009 | ATRN | Atrinsic, Inc. | Katz Burton | Chief Executive Off ... | Option Exercise | A | 0.00 | 275,000 | 0 | 275,000 | |
Jun 30 2009 | ATRN | Atrinsic, Inc. | Katz Burton | Chief Executive Off ... | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Jun 30 2009 | ATRN | Atrinsic, Inc. | Katz Burton | Chief Executive Off ... | Option Exercise | D | 10.92 | 300,000 | 3,276,000 | 0 | |
Jun 30 2009 | ATRN | Atrinsic, Inc. | BURSTEIN LAWRENCE | Director | Grant | A | 0.00 | 3,892 | 0 | 14,033 | 10.1 K to 14 K (+38.38 %) |
Jun 30 2009 | ATRN | Atrinsic, Inc. | CHAZEN JEROME A | Director | Grant | A | 0.00 | 11,392 | 0 | 12,185 | 793 to 12.2 K (+1,436.57 %) |
Jun 30 2009 | ATRN | Atrinsic, Inc. | STOLLMAN ANDREW | President | Option Exercise | A | 0.00 | 275,000 | 0 | 275,000 | |
Jun 30 2009 | ATRN | Atrinsic, Inc. | STOLLMAN ANDREW | President | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Jun 30 2009 | ATRN | Atrinsic, Inc. | STOLLMAN ANDREW | President | Option Exercise | D | 10.92 | 300,000 | 3,276,000 | 0 | |
Nov 26 2008 | ATRN | Atrinsic, Inc. | Trinad Capital Master Fund Ltd ... | 10% Owner | Buy | P | 1.17 | 25,000 | 29,290 | 2,338,170 | 2.3 M to 2.3 M (+1.08 %) |
Sep 03 2008 | ATRN | Atrinsic, Inc. | Trinad Capital Master Fund Ltd ... | 10% Owner | Buy | P | 4.03 | 25,000 | 100,655 | 2,313,170 | 2.3 M to 2.3 M (+1.09 %) |
Aug 07 2008 | ATRN | Atrinsic, Inc. | STOLLMAN ANDREW | President | Option Exercise | A | 10.92 | 300,000 | 3,276,000 | 300,000 | |
Aug 07 2008 | ATRN | Atrinsic, Inc. | STOLLMAN ANDREW | President | Option Exercise | A | 9.98 | 67,607 | 674,718 | 67,607 | |
Aug 07 2008 | ATRN | Atrinsic, Inc. | STOLLMAN ANDREW | President | Option Exercise | A | 4.44 | 30,423 | 135,078 | 30,423 | |
Aug 07 2008 | ATRN | Atrinsic, Inc. | STOLLMAN ANDREW | President | Option Exercise | A | 3.70 | 30,423 | 112,565 | 30,423 | |
Aug 07 2008 | ATRN | Atrinsic, Inc. | STOLLMAN ANDREW | President | Option Exercise | A | 3.42 | 30,423 | 104,047 | 30,423 | |
Aug 07 2008 | ATRN | Atrinsic, Inc. | STOLLMAN ANDREW | President | Option Exercise | A | 8.43 | 70,987 | 598,420 | 70,987 | |
Aug 07 2008 | ATRN | Atrinsic, Inc. | STOLLMAN ANDREW | President | Option Exercise | A | 10.86 | 273,809 | 2,973,566 | 273,809 | |
Aug 07 2008 | ATRN | Atrinsic, Inc. | STOLLMAN ANDREW | President | Buy | J | 0.00 | 443,085 | 0 | 443,085 | 0 to 443.1 K |
Aug 07 2008 | ATRN | Atrinsic, Inc. | Katz Burton | Chief Executive Off ... | Option Exercise | A | 10.92 | 300,000 | 3,276,000 | 300,000 | |
Jul 29 2008 | ATRN | Atrinsic, Inc. | ZAREF ANDREW | Chief Financial Off ... | Option Exercise | A | 4.16 | 200,000 | 832,000 | 200,000 | |
Jun 17 2008 | ATRN | Atrinsic, Inc. | Trinad Capital Master Fund Ltd ... | 10% Owner | Buy | P | 4.30 | 10,000 | 42,968 | 2,288,170 | 2.3 M to 2.3 M (+0.44 %) |
Jun 12 2008 | ATRN | Atrinsic, Inc. | Trinad Capital Master Fund Ltd ... | 10% Owner | Buy | P | 4.36 | 10,000 | 43,601 | 2,278,170 | 2.3 M to 2.3 M (+0.44 %) |
Jun 12 2008 | ATRN | Atrinsic, Inc. | Trinad Capital Master Fund Ltd ... | 10% Owner | Buy | P | 4.31 | 10,000 | 43,107 | 2,268,170 | 2.3 M to 2.3 M (+0.44 %) |
Jun 09 2008 | ATRN | Atrinsic, Inc. | Trinad Capital Master Fund Ltd ... | 10% Owner | Buy | P | 4.21 | 10,000 | 42,071 | 2,258,170 | 2.2 M to 2.3 M (+0.44 %) |
Jun 02 2008 | ATRN | Atrinsic, Inc. | Trinad Capital Master Fund Ltd ... | 10% Owner | Buy | P | 4.00 | 35,000 | 140,000 | 2,248,170 | 2.2 M to 2.2 M (+1.58 %) |
Jun 02 2008 | ATRN | Atrinsic, Inc. | Trinad Capital Master Fund Ltd ... | 10% Owner | Buy | P | 4.56 | 35,000 | 159,751 | 2,213,170 | 2.2 M to 2.2 M (+1.61 %) |
Feb 07 2008 | ATRN | Atrinsic, Inc. | Trinad Capital Master Fund Ltd ... | Director | Grant | A | 0.00 | 676,072 | 0 | 2,178,170 | 1.5 M to 2.2 M (+45.01 %) |
Feb 07 2008 | ATRN | Atrinsic, Inc. | HARVEY DANIEL | Chief Financial Off ... | Option Exercise | A | 9.08 | 13,521 | 122,771 | 13,521 | |
Feb 07 2008 | ATRN | Atrinsic, Inc. | HARVEY DANIEL | Chief Financial Off ... | Option Exercise | A | 8.28 | 13,521 | 111,954 | 13,521 | |
Feb 07 2008 | ATRN | Atrinsic, Inc. | MACHINIST ROBERT | Director | Option Exercise | A | 8.25 | 16,902 | 139,442 | 16,902 | |
Feb 07 2008 | ATRN | Atrinsic, Inc. | MACHINIST ROBERT | Director | Option Exercise | A | 8.86 | 4,225 | 37,434 | 4,225 | |
Feb 07 2008 | ATRN | Atrinsic, Inc. | MACHINIST ROBERT | Director | Option Exercise | A | 9.39 | 4,225 | 39,673 | 4,225 | |
Feb 07 2008 | ATRN | Atrinsic, Inc. | MACHINIST ROBERT | Director | Option Exercise | A | 7.77 | 4,225 | 32,828 | 4,225 | |
Feb 07 2008 | ATRN | Atrinsic, Inc. | MACHINIST ROBERT | Director | Option Exercise | A | 7.43 | 4,225 | 31,392 | 4,225 | |
Feb 07 2008 | ATRN | Atrinsic, Inc. | MACHINIST ROBERT | Director | Option Exercise | A | 9.21 | 4,225 | 38,912 | 4,225 | |
Feb 07 2008 | ATRN | Atrinsic, Inc. | MACHINIST ROBERT | Director | Option Exercise | A | 7.57 | 4,225 | 31,983 | 4,225 | |
Feb 07 2008 | ATRN | Atrinsic, Inc. | MACHINIST ROBERT | Director | Option Exercise | A | 8.52 | 4,225 | 35,997 | 4,225 | |
Feb 07 2008 | ATRN | Atrinsic, Inc. | MACHINIST ROBERT | Director | Buy | J | 0.00 | 10,141 | 0 | 10,141 | 0 to 10.1 K |
Feb 07 2008 | ATRN | Atrinsic, Inc. | BURSTEIN LAWRENCE | Director | Option Exercise | A | 13.31 | 4,225 | 56,235 | 4,225 | |
Feb 07 2008 | ATRN | Atrinsic, Inc. | BURSTEIN LAWRENCE | Director | Option Exercise | A | 8.69 | 4,225 | 36,715 | 4,225 | |
Feb 07 2008 | ATRN | Atrinsic, Inc. | BURSTEIN LAWRENCE | Director | Option Exercise | A | 8.97 | 4,225 | 37,898 | 4,225 | |
Feb 07 2008 | ATRN | Atrinsic, Inc. | BURSTEIN LAWRENCE | Director | Option Exercise | A | 5.69 | 4,225 | 24,040 | 4,225 | |
Feb 07 2008 | ATRN | Atrinsic, Inc. | BURSTEIN LAWRENCE | Director | Option Exercise | A | 10.72 | 4,225 | 45,292 | 4,225 | |
Feb 07 2008 | ATRN | Atrinsic, Inc. | BURSTEIN LAWRENCE | Director | Option Exercise | A | 10.75 | 4,225 | 45,419 | 4,225 | |
Feb 07 2008 | ATRN | Atrinsic, Inc. | BURSTEIN LAWRENCE | Director | Option Exercise | A | 6.24 | 4,225 | 26,364 | 4,225 | |
Feb 07 2008 | ATRN | Atrinsic, Inc. | BURSTEIN LAWRENCE | Director | Option Exercise | A | 4.63 | 4,225 | 19,562 | 4,225 | |
Feb 07 2008 | ATRN | Atrinsic, Inc. | BURSTEIN LAWRENCE | Director | Option Exercise | A | 4.81 | 4,225 | 20,322 | 4,225 | |
Feb 07 2008 | ATRN | Atrinsic, Inc. | BURSTEIN LAWRENCE | Director | Option Exercise | A | 4.59 | 4,225 | 19,393 | 4,225 | |
Feb 07 2008 | ATRN | Atrinsic, Inc. | BURSTEIN LAWRENCE | Director | Option Exercise | A | 5.32 | 4,225 | 22,477 | 4,225 | |
Feb 07 2008 | ATRN | Atrinsic, Inc. | BURSTEIN LAWRENCE | Director | Option Exercise | A | 8.06 | 4,225 | 34,054 | 4,225 | |
Feb 07 2008 | ATRN | Atrinsic, Inc. | BURSTEIN LAWRENCE | Director | Option Exercise | A | 7.66 | 4,225 | 32,364 | 4,225 | |
Feb 07 2008 | ATRN | Atrinsic, Inc. | BURSTEIN LAWRENCE | Director | Option Exercise | A | 9.75 | 4,225 | 41,194 | 4,225 | |
Feb 07 2008 | ATRN | Atrinsic, Inc. | BURSTEIN LAWRENCE | Director | Option Exercise | A | 8.86 | 4,225 | 37,434 | 4,225 | |
Feb 07 2008 | ATRN | Atrinsic, Inc. | BURSTEIN LAWRENCE | Director | Option Exercise | A | 9.39 | 4,225 | 39,673 | 4,225 | |
Feb 07 2008 | ATRN | Atrinsic, Inc. | BURSTEIN LAWRENCE | Director | Option Exercise | A | 7.77 | 4,225 | 32,828 | 4,225 | |
Feb 07 2008 | ATRN | Atrinsic, Inc. | BURSTEIN LAWRENCE | Director | Option Exercise | A | 7.43 | 4,225 | 31,392 | 4,225 | |
Feb 07 2008 | ATRN | Atrinsic, Inc. | BURSTEIN LAWRENCE | Director | Option Exercise | A | 9.21 | 4,225 | 38,912 | 4,225 | |
Feb 07 2008 | ATRN | Atrinsic, Inc. | BURSTEIN LAWRENCE | Director | Option Exercise | A | 7.57 | 4,225 | 31,983 | 4,225 | |
Feb 07 2008 | ATRN | Atrinsic, Inc. | BURSTEIN LAWRENCE | Director | Option Exercise | A | 8.52 | 4,225 | 35,997 | 4,225 | |
Feb 07 2008 | ATRN | Atrinsic, Inc. | BURSTEIN LAWRENCE | Director | Buy | J | 0.00 | 10,141 | 0 | 10,141 | 0 to 10.1 K |
Jan 31 2008 | ATRN | Atrinsic, Inc. | Legator Allan | CFO and Secretary | Option Exercise | M | 0.48 | 50,000 | 24,000 | 240,548 | |
Jan 31 2008 | ATRN | Atrinsic, Inc. | Legator Allan | CFO and Secretary | Buy | M | 0.48 | 50,000 | 24,000 | 50,000 | 0 to 50 K |
Dec 03 2007 | ATRN | Atrinsic, Inc. | Trinad Capital Master Fund Ltd ... | 10% Owner | Buy | P | 14.00 | 12,500 | 175,000 | 1,495,000 | 1.5 M to 1.5 M (+0.84 %) |
Sep 27 2007 | ATRN | Atrinsic, Inc. | Klier Gil | Director | Option Exercise | A | 14.00 | 25,000 | 350,000 | 25,000 |